This announcement is a separate document:
駅探：内部統制報告書－第22期(2023/04/01－2024/03/31)
Ekitan: Internal Control Report - 22nd Period (April 1, 2023 - March 31, 2024)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
17:47
Fosun Pharma: Controlled subsidiary obtains approval for pharmaceutical clinical trials.
Shanghai Fosun Pharmaceutical-1.50%
17:44
TENCENT has conducted large-scale repurchases for four consecutive days! Today it spent another 1.5 billion Hong Kong dollars to buy back shares.
TENCENT-1.02%
17:42
Kremlin: (In comment on the West's new round of military aid to Ukraine) The Biden administration in the USA is determined to utilize its last moments in power to ensure the continuation of the conflict in Ukraine.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.